Amphastar Pharmaceuticals (AMPH) EBT Margin (2013 - 2026)

Amphastar Pharmaceuticals' EBT Margin history runs 14 years deep, the most recent figure standing at 5.87% for Q1 2026.

• In Q1 2026, EBT Margin fell 1223.0% year-over-year to 5.87%; the TTM figure through Mar 2026 stood at 3.63% (down 2801.0% YoY), while the FY2025 annual figure was 0.74%, down 2740.0% from the prior year.
• EBT Margin was 5.87% for Q1 2026 at Amphastar Pharmaceuticals, up from 53.0% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 35.25% in Q3 2023 to a low of 53.0% in Q4 2025.
• Historically, EBT Margin has averaged 18.16% across 5 years, with a median of 23.21% in 2023.
• The sharpest annual moves came in 2022 and 2025: EBT Margin jumped 1916 bps in 2022, then plunged 7947 bps in 2025.
• A 5-year view of EBT Margin shows it stood at 30.56% in 2022, then fell by 24 bps to 23.21% in 2023, then grew by 14 bps to 26.47% in 2024, then sank by 300 bps to 53.0% in 2025, then jumped by 111 bps to 5.87% in 2026.
• The last three EBT Margin figures came in at 5.87% (Q1 2026), 53.0% (Q4 2025), and 11.21% (Q3 2025), per Business Quant data.